Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome

N Yoshizawa, Y Kusumi, K Matsumoto, S Oshima… - Nephron, 1989 - karger.com
N Yoshizawa, Y Kusumi, K Matsumoto, S Oshima, A Takeuchi, O Kawamura, T Kubota…
Nephron, 1989karger.com
Peripheral blood mononuclear cells (PBMC) from patients with minimal-change nephrotic
syndrome (MCNS) were tested for their ability to produce a factor which increases the
urinary protein excretion levels of rats. It was shown that enhanced proteinuria can be
produced in 8-hour urine specimens from rats by the injection of concentrated supernatants
of cultured concanavalin-A-stimulated PBMC of patients with MCNS, but not from other
nephrotics or normal subjects. The increase in urinary protein excretion was associated with …
Abstract
Peripheral blood mononuclear cells (PBMC) from patients with minimal-change nephrotic syndrome (MCNS) were tested for their ability to produce a factor which increases the urinary protein excretion levels of rats. It was shown that enhanced proteinuria can be produced in 8-hour urine specimens from rats by the injection of concentrated supernatants of cultured concanavalin-A-stimulated PBMC of patients with MCNS, but not from other nephrotics or normal subjects. The increase in urinary protein excretion was associated with a significant alteration of glomerular epithelial cells similar to that seen in MCNS. These results suggest that in MCNS, PBMC release a factor, which we termed a glomerular permeability factor (GPF), causing changes in glomerular permeability with resulting proteinuria.
Karger